Merck, known as MSD outside the United States and Canada, announced today the creation of the Kenneth C. Frazier Award for Maternal Health Equity, a grant award that will be bestowed annually to one organization in recognition of its commitment to and progress toward more equitable, high-quality maternal health care. The award will be granted by Merck for Mothers, Merck’s global initiative…
Raydiant Oximetry has received a $3M grant from the government of Ireland. The company now plans to build a team in Ireland. As C-sections continue to rise worldwide, more mothers and babies are at risk from perinatal complications. Raydiant Oximetry, a Fogarty Innovation graduate, is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth and recently received a…
Kindbody today announced the launch of Kindbody360, a dynamic and integrative solution focused on holistic care. Kindbody360 deftly augments Kindbody’s fertility and family-building offering with mental, physical, and emotional support from pre to postpartum, in-clinic, online and via its telehealth platform. Leveraging proprietary technology, the offering expands the reach of the company’s brick-and-mortar locations, mobile pop-ups, and 300+ partner clinics, furthering its…
U.S. based femtech startup LiquidGoldConcept announced it has been awarded an additional $55,000 in National Institutes of Health (NIH) funding in support of its Lactation Simulation Models (LSM) and Newborn Oral Assessment and Latch Simulators (NORALSim). The new grant is in addition to $250,000 in NIH support the company received in July of 2020 for its breastfeeding training technology. The $55,000 grant is through the National Centers for Clinical and Translational Science (NCATS), a…
Sera Prognostics, “The Pregnancy Company”, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the completion of a $100 million Series E financing. Several leading healthcare-focused institutional investors have joined this financing round, including Vivo Capital, aMoon Fund, Parian Global, and others, led by existing investors Anthem, Inc., and Blue Ox Healthcare…
Earlier today Mirvie announced it is making rapid progress toward developing a simple, personalized blood test with the potential for early detection of pregnancy complications, such as preterm birth, preeclampsia and gestational diabetes, which affect 1 in 5 women. Currently, there is no reliable way to identify if a mother is at risk for these significant pregnancy complications. Pregnancy complications, such as…
Natera, a global leader in non-invasive genetic testing and analysis of cfDNA, and Tesis Labs, a US multi-region lab services provider with labs in Colorado, Texas and Arizona, announced a strategic partnership in the field of prenatal genetic testing. The collaboration will allow Tesis to broaden its portfolio of genetic testing offerings and participate in the fast growing screening market for over 4 million pregnancies in the…
Cleo, a leading family benefits platform supporting working families in the planning stage through the teenage years, today announced a $40 million Series C investment led by Transformation Capital, with participation from Glynn Capital, PruVen Capital and Gaingels and existing investors Greylock, NEA and Felicis. In conjunction with this round, Transformation Capital Managing Partner, Mike Dixon will join Cleo’s Board. This round…
